<DOC>
	<DOC>NCT00174473</DOC>
	<brief_summary>This is a study to investigate the pharmacokinetics, safety and tolerability of several doses of voriconazole, intravenous and oral suspension formulations, in children</brief_summary>
	<brief_title>A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children</brief_title>
	<detailed_description />
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Children who require a systemic antifungal agent for the prevention of systemic fungal infection Children who are receiving medications which cannot be taken concomitantly with voriconazole.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>